Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors
Keyword(s):
2020 ◽
Vol 26
(3)
◽
pp. 758-758
◽
2008 ◽
Vol 14
(5)
◽
pp. 1571-1580
◽
2007 ◽
Vol 7
(2)
◽
pp. 149-155
◽